Search Results 171-180 of 11333 for Antifungal Resistance

  1. Cladribine (oral route) - Mayo Clinic

    May make these infections active again. Infection (eg, bacterial, viral, parasitic, and fungal), acute—Must be treated first before using this medicine.

  2. A Clinical Study Of KTX-2001 In Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

    ... resistant prostate cancer. The study aims to ... resistant prostate cancer, and measuring how ... Active, uncontrolled, bacterial, fungal, or viral ...

  3. Ergocalciferol (oral route) - Side effects & dosage - Mayo Clinic

    Ergocalciferol capsule is used to treat hypoparathyroidism (underactive parathyroid glands), refractory rickets (vitamin D resistant rickets), and familial ...

  4. Prednisone (oral route) - Mayo Clinic

    May make these conditions worse. Fungal infections or; Herpes simplex ... Prednisone may lower your body's resistance and the vaccine may not work as ...

  5. Study Of Pembrolizumab (MK-3475) Combination Therapies In Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) - Mayo Clinic

    Study Of Pembrolizumab (MK-3475) Combination Therapies In Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) ... antifungals; macrolide ...

  6. A Study To Investigate The Effectiveness And Safety Of Pf-04965842 In Subjects Aged 12 Years And Over, With Moderate To Severe Atopic Dermatitis With The Option Of Rescue Treatment In Flaring Subjects - Mayo Clinic

    ... antifungals within 2 weeks prior to Day 1, or ... resistance are <5% or an acceptable alternative ... If the current incidence rates of multi-drug resistant ...

  7. Infectious Diseases - Mayo Clinic News Network

    Antimicrobial Awareness Week, Nov. 18–24, serves as a global call to action to address antimicrobial resistance (AMR) — a growing public health concern that ...

  8. A Pilot Study To Evaluate The Molecular And Biological Phenotype Of Peripheral Immune Cells In Solid Tumor Patients - Mayo Clinic

    The purpose of this study is to investigate for potential mechanisms underlying the sensitivity and resistance to immune checkpoint modulating agents that ...

  9. Funding - Infectious Diseases Lab - Mayo Clinic Research

    Antibacterial Resistance Leadership Group, NIH, 12/2009 to 11/2026. Ritu Banerjee, M.D., Ph.D., Vanderbilt University, principal investigator; Robin Patel, M.D. ...

  10. Nipunie S. Rajapakse, M.D., M.P.H. - Doctors and Medical Staff - Mayo Clinic

    Expertise in the management of pediatric infections caused by resistant organisms (e.g. MRSA, multi-drug resistant gram negative bacteria etc). In addition to ...